跳至主要内容
临床试验/NCT07694050
NCT07694050已完成不适用

Choosing an Access for Endovascular Treatment of Femoral-popliteal Segment Occlusions

Pirogov Russian National Research Medical University1 个研究点 分布在 1 个国家目标入组 304 人开始时间: 2024年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
304
试验地点
1
主要终点
Hematoma at the access point

研究概览

简要总结

The aim of this study is to compare the shoulder and femoral approaches used in the endovascular treatment of occlusive lesions of the femoral-popliteal segment of the lower extremity arteries in terms of the frequency of complications. The aim of the study is to answer the following main questions: 1. Does the use of the shoulder approach reduce the overall number of complications compared to the femoral approach? 2. Does the use of the shoulder approach reduce the number of complications requiring surgical intervention compared to the femoral approach? 3. Does the use of a brachial approach reduce the number of technically successful interventions compared to a femoral approach? Researchers will compare the number of complications associated with a brachial approach compared to a femoral approach using closure devices for the revascularization of occlusions in the femoral-popliteal segment of the lower extremity arteries. During the planned revascularization procedure, participants will undergo catheterization of the brachial or common femoral artery. Complications related to radiation therapy will be recorded by doctors within 72 hours after the intervention.

详细描述

The purpose of the study: to compare the complication rate of the shoulder and retrograde femoral access in elderly patients with occlusive lesions of the femoral-popliteal segment of the lower extremity arteries.

Scientific hypotheses:

  1. The shoulder access has a lower number of complications compared to the femoral access
  2. The shoulder access has a lower number of complications requiring surgical intervention compared to the femoral access
  3. The shoulder access has a comparable % of success of the main intervention with the femoral access Inclusion criteria: arterial diameter at the access site of at least 3 mm, indications for endovascular intervention on the lower extremity arteries, age of 60 years or more, and patient consent to participate in the study.

Exclusion criteria: inability to perform an access due to stenotic lesions of the above-mentioned arteries (common femoral, iliac, axillary, subclavian arteries, brachiocephalic trunk); height more than 180 cm; presence of concomitant pathology limiting the survival of patients; pathology of the blood coagulation system (hemophilia, thrombocytopathies, etc.), previously performed catheterization through the access artery.

The required sample size was calculated using the M. Blanda method for a study with increased accuracy. The required level of significance (α) was 0.05, and the study's power was 95%. The estimated complication rates in the Femoral and Brachial groups were assumed to be 2% and 9%, respectively. Under these conditions, the estimated sample size was 269 patients. The planned loss rate during the study was 5%. Therefore, the minimum sample size was 283 patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • arterial diameter at the access site of at least 3 mm, indications for endovascular intervention on the lower extremity arteries,
  • age of 60 years or more, and patient consent to participate in the study.

排除标准

  • inability to perform an access due to stenotic lesions of the above-mentioned arteries (common femoral artery, iliac arteries, axillary artery, subclavian artery, and brachiocephalic trunk);
  • height exceeding 180 cm;
  • presence of concomitant pathology that limits patient survival; coagulation system pathology (hemophilia, thrombocytopathies, etc.)
  • previous arterial access catheterizations.

研究组 & 干预措施

Brachial

Active Comparator

Brachial artery catheterization

干预措施: Brachial artery catheterization (Procedure)

Femoral

Experimental

Femoral artery catheterization

干预措施: Femoral artery catheterization (Procedure)

结局指标

主要结局

Hematoma at the access point

时间窗: Within 72 hours after artery catheterization

Hematoma at the access point

Acute artery occlusion

时间窗: Within 72 hours after artery catheterization

Acute artery occlusion

Post-catheterization aneurysm that required surgery

时间窗: Within 72 hours after radial artery catheterization

Post-catheterization aneurysm that required surgery

Technical success of access

时间窗: Perioperative/Periprocedural

Technical success of access

Technical success of the index procedure

时间窗: Perioperative/Periprocedural

Technical success of the index procedure

Conversion to another access

时间窗: Perioperative/Periprocedural

Conversion to another access

次要结局

  • Total number of complications(Within 72 hours after radial artery catheterization)
  • Total number of complications that required surgery(Within 72 hours after radial artery catheterization)

研究者

发起方
Pirogov Russian National Research Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aleksandr V. Bocharov, PhD, MD

Clinical Professor, PhD, MD

Pirogov Russian National Research Medical University

研究点 (1)

Loading locations...

相似试验